Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 110

Similar articles for PubMed (Select 23946789)

1.

Annexin A2 is not a good biomarker for hepatocellular carcinoma in cirrhosis.

Liu Z, Ling Q, Wang J, Xie H, Xu X, Zheng S.

Oncol Lett. 2013 Jul;6(1):125-129. Epub 2013 May 8.

2.

Expression characteristics and diagnostic value of annexin A2 in hepatocellular carcinoma.

Zhang HJ, Yao DF, Yao M, Huang H, Wu W, Yan MJ, Yan XD, Chen J.

World J Gastroenterol. 2012 Nov 7;18(41):5897-904. doi: 10.3748/wjg.v18.i41.5897.

3.

Evaluation of annexin II as a potential serum marker for hepatocellular carcinoma using a developed sandwich ELISA method.

Ji NY, Park MY, Kang YH, Lee CI, Kim DG, Yeom YI, Jang YJ, Myung PK, Kim JW, Lee HG, Kim JW, Lee K, Song EY.

Int J Mol Med. 2009 Dec;24(6):765-71.

PMID:
19885616
4.

Evaluation of serum clusterin as a surveillance tool for human hepatocellular carcinoma with hepatitis B virus related cirrhosis.

Wang Y, Liu YH, Mai SJ, He LJ, Liao YJ, Deng HX, Guan XY, Zeng YX, Kung HF, Xie D.

J Gastroenterol Hepatol. 2010 Jun;25(6):1123-8. doi: 10.1111/j.1440-1746.2009.06205.x.

PMID:
20594228
5.

Annexin A2 expression and phosphorylation are up-regulated in hepatocellular carcinoma.

Mohammad HS, Kurokohchi K, Yoneyama H, Tokuda M, Morishita A, Jian G, Shi L, Murota M, Tani J, Kato K, Miyoshi H, Deguchi A, Himoto T, Usuki H, Wakabayashi H, Izuishi K, Suzuki Y, Iwama H, Deguchi K, Uchida N, Sabet EA, Arafa UA, Hassan AT, El-Sayed AA, Masaki T.

Int J Oncol. 2008 Dec;33(6):1157-63.

PMID:
19020748
6.

Annexin A2 is a discriminative serological candidate in early hepatocellular carcinoma.

Sun Y, Gao G, Cai J, Wang Y, Qu X, He L, Liu F, Zhang Y, Lin K, Ma S, Yang X, Qian X, Zhao X.

Carcinogenesis. 2013 Mar;34(3):595-604. doi: 10.1093/carcin/bgs372. Epub 2012 Nov 27.

8.

Chronic hepatitis B virus infection in Asian countries.

Merican I, Guan R, Amarapuka D, Alexander MJ, Chutaputti A, Chien RN, Hasnian SS, Leung N, Lesmana L, Phiet PH, Sjalfoellah Noer HM, Sollano J, Sun HS, Xu DZ.

J Gastroenterol Hepatol. 2000 Dec;15(12):1356-61. Review.

PMID:
11197043
9.

Elevated plasma osteopontin level is predictive of cirrhosis in patients with hepatitis B infection.

Zhao L, Li T, Wang Y, Pan Y, Ning H, Hui X, Xie H, Wang J, Han Y, Liu Z, Fan D.

Int J Clin Pract. 2008 Jul;62(7):1056-62. Epub 2007 May 30.

PMID:
17537188
10.

Long-term prognosis after resection of hepatocellular carcinoma associated with hepatitis B-related cirrhosis.

Poon RT, Fan ST, Lo CM, Liu CL, Ng IO, Wong J.

J Clin Oncol. 2000 Mar;18(5):1094-101.

PMID:
10694562
11.

Hepatitis C virus in chronic liver disease and hepatocellular carcinoma in Taiwan.

Chen DS.

Princess Takamatsu Symp. 1995;25:27-32. Review.

PMID:
8875606
12.

Application of HBx-induced anti-URGs as early warning biomarker of cirrhosis and HCC.

Wang W, Zhao LJ, Wang Y, Tao QY, Feitelson MA, Zhao P, Ren H, Qi ZT.

Cancer Biomark. 2011-2012;11(1):29-39. doi: 10.3233/CBM-2012-0261.

PMID:
22820138
13.

Inhibition of Annexin A2 gene transcription is a promising molecular target for hepatoma cell proliferation and metastasis.

Dong Z, Yao M, Zhang H, Wang L, Huang H, Yan M, Wu W, Yao D.

Oncol Lett. 2014 Jan;7(1):28-34. Epub 2013 Nov 6.

14.

Up-regulation of annexin A2 expression predicates advanced clinicopathological features and poor prognosis in hepatocellular carcinoma.

Zhang H, Yao M, Wu W, Qiu L, Sai W, Yang J, Zheng W, Huang J, Yao D.

Tumour Biol. 2015 Jun 26. [Epub ahead of print]

PMID:
26109000
15.

[Expression of GST-pi and HBV infection in hepatocellular carcinoma].

Shen LJ, Zhang ZJ, Zhang HX, Yang WB, Huang R.

Ai Zheng. 2002 Jan;21(1):29-32. Chinese.

PMID:
12500393
16.

Circulating annexin A2 as a biomarker in gastric cancer patients: correlation with clinical variables.

Tas F, Tilgen Yasasever C, Karabulut S, Tastekin D, Duranyildiz D.

Biomed Pharmacother. 2015 Feb;69:237-41. doi: 10.1016/j.biopha.2014.12.005. Epub 2014 Dec 12.

PMID:
25661364
17.

Overexpression of HBxAg in hepatocellular carcinoma and its relationship with Fas/FasL system.

Wang XZ, Chen XC, Chen YX, Zhang LJ, Li D, Chen FL, Chen ZX, Chen HY, Tao QM.

World J Gastroenterol. 2003 Dec;9(12):2671-5.

18.

[A clinicopathologic study on complications of orthotopic liver transplantation in 54 patients with chronic hepatitis B virus infection].

Pei F, Zheng J, Du J, Zhong HH, Yang JP.

Beijing Da Xue Xue Bao. 2008 Aug 18;40(4):408-14. Chinese.

19.

Serum miR-18a: a potential marker for hepatitis B virus-related hepatocellular carcinoma screening.

Li L, Guo Z, Wang J, Mao Y, Gao Q.

Dig Dis Sci. 2012 Nov;57(11):2910-6. doi: 10.1007/s10620-012-2317-y. Epub 2012 Aug 5.

PMID:
22865399
20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk